Skip to Content

Merrimack is a biopharmaceutical company based in Cambridge, Massachusetts that is outthinking cancer to ensure that patients and their families live fulfilling lives. Its mission is to transform cancer care through the smart design and development of targeted solutions based on a deep understanding of cancer pathways and biological markers. All of Merrimack's development programs fit into its strategy of 1) understanding the biological problems it is trying to solve, 2) designing specific solutions and 3) developing those solutions for biomarker-selected patients. This three-pronged strategy seeks to optimize patient outcomes.

Investors

Press Releases

November 2, 2023

Summary Toggle Merrimack Reports Third Quarter 2023 Financial Results

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Nov. 2, 2023-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its third quarter 2023 financial results for the period ended September 30, 2023 . “During the third quarter we saw interest income on our cash and

PDF Version
August 3, 2023

Summary Toggle Merrimack Reports Second Quarter 2023 Financial Results

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Aug. 3, 2023-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its second quarter 2023 financial results for the period ended June 30, 2023 . “We were excited to see the announcement from Ipsen that the U.S.

PDF Version
May 4, 2023

Summary Toggle Merrimack Reports First Quarter 2023 Financial Results

CAMBRIDGE, Mass. --(BUSINESS WIRE)--May 4, 2023-- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its first quarter 2023 financial results for the period ended March 31, 2023 . “During the first quarter of 2023 our operating expenses remained

PDF Version

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Back to top

Merrimack Pharmaceuticals, Inc.
One Broadway, 14th floor
Cambridge, MA 02142
617-720-8606
info@merrimack.com

© 2023 Merrimack Pharmaceuticals.